Speaker illustration

Doctor Jakob Doerler

National Hospital Klagenfurt, Klagenfurt (Austria)

Member of:

European Society of Cardiology
Heart Failure Association

Prasugrel compared to ticagrelor in primary PCI

Event: ESC Congress 2020

Topic: Pharmacotherapy

Session: Advances in Treatment of Acute Coronary Syndrome

Thumbnail

Pre-treatment with potent P2Y12 receptor inhibitors is associated with reduced in-hospital mortality in a real world setting of primary percutaneous coronary intervention

Event: ESC Congress 2016

Topic: Thrombosis and platelets

Session: Clinical platelet studies

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb